Indice
Part I
1 Prehypertension: Definitions, Clinical Significance
and Therapeutic Approaches—To Treat or not to Treat? 2 Clinical Significance and Treatment Requirements in White Coat
and Masked Hypertension 3 Resistant Hypertension: Epidemiological and Evolving
Therapeutic Concepts 4 Primary Aldosteronism: Rare or Common Condition
in Hypertensive Patients and Normotensive Individuals? 5 Hypertension in the Very Old: Special Features,
Therapeutic Approaches, and Problems
Part II
6 Ambulatory Blood Pressure in Clinical Practice: Clinical
Relevance of Circadian Rhythm and Nocturnal Dip 7 Morning Surge in Blood Pressure in Hypertension:
Clinical Relevance, Prognostic Significance,
and Therapeutic Approach 8 Short-Term and Long-Term Blood Pressure Variability
9 Home Blood Pressure Monitoring in Hypertension
10 Obstructive Sleep Apnea 11 Hypertension, Obesity, and Metabolic Syndrome 12 Salt, Hypertension, and Cardiovascular Disease
13 The Optic Fundus and Retinal Circulation:
New Technology for an Old Examination Part III
14 Arterial Stiffness as an Early Marker of Organ Damage
15 Central Aortic Pressure: The Next Frontier
in Blood Pressure Measurement?
16 Assessment of Total Cardiovascular Risk in Hypertension:
The Role of Subclinical Organ Damage 17 The Microcirculation and Hypertension
18 Smoking, Nicotine and Blood Pressure
19 Biomarkers in Hypertension Part IV
20 Antihypertensive Therapy Benefits: Pleiotropic Versus
Blood Pressure-Dependent Mechanisms 21 Blood Pressure Targets with Antihypertensive Treatment 22 The Role of the Polypill in Hypertension 23 J-Curve Phenomenon: Does It Exist?
24 Residual Risk in Treated Hypertension 25 Poor BP Control in the Hypertensive Population:
Which Factors are Involved?
26 Ramadan Fasting in Health and Disease
27 Postmenopausal Hormone Therapy and Blood Pressure
28 Treating Pain and Inflammation in Hypertension
29 Sexual Function in Untreated and Treated Hypertension 30 Cognitive Function and Dementia in Hypertension:
Epidemiologic and Therapeutic Aspects
31 Can Hypertension Be Prevented? 32 Atrial Fibrillation. Modern Epidemiologic
and Therapeutic Aspects
33 Genetics and Hypertension: Which Information
for Clinical Practice 34 Dual Blockade of the Renin–Angiotensin–Aldosterone System:
Benefits Versus Adverse Outcomes 35 The Long-Term Effects of RAAS Blockade on Renal Function